It is important to note that these genes exhibited the same differential expression pattern as their peripheral biomarkers, with GFAP upregulated in AD100, 101, 102, 103, 104 and VGF downregulated in AD.105, 106. This evidence concerns the gene GFAP and Alzheimer disease.